Literature DB >> 22252864

Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.

Jon Cuccui1, Timothy S Milne, Nicholas Harmer, Alison J George, Sarah V Harding, Rachel E Dean, Andrew E Scott, Mitali Sarkar-Tyson, Brendan W Wren, Richard W Titball, Joann L Prior.   

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to regions of Southeast Asia and Northern Australia. Both humans and a range of other animal species are susceptible to melioidosis, and the production of a group 3 polysaccharide capsule in B. pseudomallei is essential for virulence. B. pseudomallei capsular polysaccharide (CPS) I comprises unbranched manno-heptopyranose residues and is encoded by a 34.5-kb locus on chromosome 1. Despite the importance of this locus, the role of all of the genes within this region is unclear. We inactivated 18 of these genes and analyzed their phenotype using Western blotting and immunofluorescence staining. Furthermore, by combining this approach with bioinformatic analysis, we were able to develop a model for CPS I biosynthesis and export. We report that inactivating gmhA, wcbJ, and wcbN in B. pseudomallei K96243 retains the immunogenic integrity of the polysaccharide despite causing attenuation in the BALB/c murine infection model. Mice immunized with the B. pseudomallei K96243 mutants lacking a functional copy of either gmhA or wcbJ were afforded significant levels of protection against a wild-type B. pseudomallei K96243 challenge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252864      PMCID: PMC3294636          DOI: 10.1128/IAI.05805-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.

Authors:  S M Jones; J F Ellis; P Russell; K F Griffin; P C F Oyston
Journal:  J Med Microbiol       Date:  2002-12       Impact factor: 2.472

2.  Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei.

Authors:  Matthew T G Holden; Richard W Titball; Sharon J Peacock; Ana M Cerdeño-Tárraga; Timothy Atkins; Lisa C Crossman; Tyrone Pitt; Carol Churcher; Karen Mungall; Stephen D Bentley; Mohammed Sebaihia; Nicholas R Thomson; Nathalie Bason; Ifor R Beacham; Karen Brooks; Katherine A Brown; Nat F Brown; Greg L Challis; Inna Cherevach; Tracy Chillingworth; Ann Cronin; Ben Crossett; Paul Davis; David DeShazer; Theresa Feltwell; Audrey Fraser; Zahra Hance; Heidi Hauser; Simon Holroyd; Kay Jagels; Karen E Keith; Mark Maddison; Sharon Moule; Claire Price; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Mark Simmonds; Sirirurg Songsivilai; Kim Stevens; Sarinna Tumapa; Monkgol Vesaratchavest; Sally Whitehead; Corin Yeats; Bart G Barrell; Petra C F Oyston; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

3.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.

Authors:  D DeShazer; D M Waag; D L Fritz; D E Woods
Journal:  Microb Pathog       Date:  2001-05       Impact factor: 3.738

7.  Relationship of Yersinia pseudotuberculosis O antigens IA, IIA, and IVB: the IIA gene cluster was derived from that of IVB.

Authors:  Elvia Pacinelli; Lei Wang; Peter R Reeves
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  Melioidosis, the great mimicker: a report of 10 cases from Malaysia.

Authors:  K C Yee; M K Lee; C T Chua; S D Puthucheary
Journal:  J Trop Med Hyg       Date:  1988-10

9.  A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.

Authors:  T Atkins; R G Prior; K Mack; P Russell; M Nelson; P C F Oyston; G Dougan; R W Titball
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.

Authors:  Mark P Stevens; Ashraful Haque; Timothy Atkins; Jim Hill; Michael W Wood; Anna Easton; Michelle Nelson; Cindy Underwood-Fowler; Richard W Titball; Gregory J Bancroft; Edouard E Galyov
Journal:  Microbiology (Reading)       Date:  2004-08       Impact factor: 2.777

View more
  28 in total

1.  Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent.

Authors:  Yuwana Podin; Mirjam Kaestli; Nicole McMahon; Jann Hennessy; Hie Ung Ngian; Jin Shyan Wong; Anand Mohana; See Chang Wong; Timothy William; Mark Mayo; Robert W Baird; Bart J Currie
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

2.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

Review 3.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 4.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

5.  Intracranial Manifestation of Melioidosis: A Case Report and Long-Term Follow-Up.

Authors:  Alba Corell; Aylin Yilmaz; Fawaz S Almotairi; Dan Farahmand
Journal:  Cureus       Date:  2020-12-29

6.  Genomic insights of beta-lactamase producing Klebsiella quasipneumoniae subsp. similipneumoniae belonging to sequence type 1699 from retail market fish, India.

Authors:  Sudha Sajeev; Muneeb Hamza; Gopalan Krishnan Sivaraman; Sandeep Ghatak; Rakshit Ojha; Suresh Kumar Mendem; Devi Murugesan; Claire Raisen; Bibek R Shome; Mark A Holmes
Journal:  Arch Microbiol       Date:  2022-07-04       Impact factor: 2.552

7.  Neutrophil extracellular traps exhibit antibacterial activity against burkholderia pseudomallei and are influenced by bacterial and host factors.

Authors:  Donporn Riyapa; Surachat Buddhisa; Sunee Korbsrisate; Jon Cuccui; Brendan W Wren; Mark P Stevens; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2012-08-27       Impact factor: 3.441

8.  Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens.

Authors:  Nicholas J Harmer; Richard Chahwan
Journal:  Virulence       Date:  2016-05-25       Impact factor: 5.882

Review 9.  Burkholderia vaccines: are we moving forward?

Authors:  Leang-Chung Choh; Guang-Han Ong; Kumutha M Vellasamy; Kaveena Kalaiselvam; Wen-Tyng Kang; Anis R Al-Maleki; Vanitha Mariappan; Jamuna Vadivelu
Journal:  Front Cell Infect Microbiol       Date:  2013-02-05       Impact factor: 5.293

10.  Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection.

Authors:  Erin P Price; Derek S Sarovich; Mark Mayo; Apichai Tuanyok; Kevin P Drees; Mirjam Kaestli; Stephen M Beckstrom-Sternberg; James S Babic-Sternberg; Timothy J Kidd; Scott C Bell; Paul Keim; Talima Pearson; Bart J Currie
Journal:  MBio       Date:  2013-07-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.